Phyllis Yerino

The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel

Brian W. Ogilvie, Phyllis Yerino, Faraz Kazmi et al. · Drug Metabolism and Disposition · 2011 · 105 citations

An Evaluation of the Dilution Method for Identifying Metabolism-Dependent Inhibitors of Cytochrome P450 Enzymes

Andrew Parkinson, Faraz Kazmi, David B. Buckley et al. · Drug Metabolism and Disposition · 2011 · 70 citations

A Long-Standing Mystery Solved: The Formation of 3-Hydroxydesloratadine Is Catalyzed by CYP2C8 But Prior Glucuronidation of Desloratadine by UDP-Glucuronosyltransferase 2B10 Is an Obligatory Requirement

Faraz Kazmi, Joanna E. Barbara, Phyllis Yerino et al. · Drug Metabolism and Disposition · 2015 · 45 citations

Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor

Faraz Kazmi, Phyllis Yerino, Joanna E. Barbara et al. · Drug Metabolism and Disposition · 2015 · 30 citations

THE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATS

Peter L. Bonate, Larry Arthaud, John D. Stuhler et al. · Drug Metabolism and Disposition · 2005 · 25 citations